|
National Stock Number(NSN): 6505-00-685-4973 (6505006854973, 006854973)
| NIIN: |
00-685-4973 |
Item Name: |
NITROFURANTOIN TABLETS |
INC: |
09544
|
| FSC: |
6505
|
Assignment Date: |
Jan-01-1961 |
CRIT: |
X |
IIG: |
09544 |
| ISC: |
5 |
Date Standardized: |
Feb-01-1975 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Aug-31-2022 |
PMIC: |
U |
FIIG: |
A510N0 |
| ESD: |
|
Schedule B: |
3004.90.9210 |
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
1 |
Originator: |
98 |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
FURADANTIN |
04489
|
NORWICH EATON PHARMACEUTICALS INC PROFESSIONAL PRODUCTS SUB OF PROCTER AND GAMBLE CO |
H |
3 |
1 |
4 |
75 |
3 |
D |
|
|
|
|
|
FURADANTIN |
04547
|
PROCTER & GAMBLE PHARMACEUTICALS, INC. |
H |
3 |
1 |
4 |
75 |
|
D |
|
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
50.000 MILLIGRAMS NITROFURANTOIN ACTIVE INGREDIENT |
| CQCT |
PRIMARY CONTAINER TYPE |
BOTTLE |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
1000.000 TABLETS |
| CSGS |
ADMINISTRATION |
ORAL |
| MDES |
MEDICAL DESIGNATION AND GRADE |
UNITED STATES PHARMACOPEIA |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| G57V |
|
Apr-01-1991 |
0 |
0 |
|
|
54 |
54|57 |
|